Phase II trial of pembrolizumab in patients with solid tumors functionally competent or deficient for the Fanconi Anemia repair pathway Conference

Villalona, M, Diaz, JP, Duan, W et al. (2018). Phase II trial of pembrolizumab in patients with solid tumors functionally competent or deficient for the Fanconi Anemia repair pathway . EUROPEAN JOURNAL OF CANCER, 103 E26-E26.

cited authors

  • Villalona, M; Diaz, JP; Duan, W; Diaz, Z; Schroeder, ED; Aparo, S; Madueno, F Vargas; Alonso, A; Cuitiva, S; Albrecht, F; Venkatappa, S; Guardiola, V; Troner, M; Walker, G; Narasimhan, G

authors

date/time interval

  • November 13, 2018 -

publication date

  • November 1, 2018

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Dublin, IRELAND

Conference

  • 30th EORTC-NCI-AACR Symposium

publisher

  • ELSEVIER SCI LTD

start page

  • E26

end page

  • E26

volume

  • 103